Latest Posts

12 Jan 2018

COOK GROUP EXPANDS BY BUYING ADJACENT VACANT GE SITE

  Cook Group, through its subsidiary Cook Properties, has agreed to purchase the former GE site near Cook’s world headquarters in Bloomington, Ind. Cook Group is expanding its medical device business into the vacant GE property on Curry Pike. This purchase allows Cook the flexibility to address some immediate space

0
12 Jan 2018

BECTON, DICKINSON COMPLETES ACQUISITION OF C.R. BARD

Becton, Dickinson (BD) has completed the acquisition of C.R. Bard, creating a new healthcare company with approximately $16 billion in annualized revenue. Vincent A Forlenza, chairman and CEO, said the combined company builds on BD’s position in medication management and infection prevention with an expanded offering of solutions across the care

0
11 Jan 2018

PRISM TRIAL EVALUATES SAFETY, EFFICACY OF INDIGO ASPIRATION SYSTE

Results of the multicenter PRISM trial were published by Richard R. Saxon, MD, et al in the  Journal of Vascular and Interventional Radiology (JVIR; 2018;29:92–100). PRISM evaluated the safety and initial efficacy of a power aspiration–based extraction technique for treatment of peripheral arterial thromboembolism using the Indigo aspiration system from Penumbra Inc.. The JVIR investigators

0
11 Jan 2018

FDA APPROVES XABLECATH BLUNT TIP SUPPORT CATHETER

  XableCath’s blunt tip support catheter has received clearance from the U.S. Food and Drug Administration (FDA). In two clinical investigator-led studies, the device was demonstrated to be a safe, effective, and easy-to-use device, enabling therapeutic options for patients with PAD,” said Johannes Dahm, MD and director of Interventional Cardiology

0
06 Jan 2018

STUDY SHOWS STEM CELL TRANSPLANT IS BETTER THAN DRUG THERAPY FOR SCLERODERMA

Photo courtesy of American College of Rheumatology   Adding irradiation before transplant improves long-term results and should change practice    Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study led by Duke Health researchers has found new cause for optimism using an

0
SHARE

Home